NEXT Biometrics Group ASA
OSE:NEXT.OL
5.96 (NOK) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) NOK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 33.717 | 48.292 | 50.755 | 58.133 | 84.436 | 108.392 | 98.159 | 92.07 | 4.571 | 6.681 | 0.038 | 1.125 |
| Cost of Revenue
| 72.567 | 33.541 | 41.782 | 49.387 | 63.865 | 77.612 | 104.014 | 185.51 | 73.807 | 0 | 0 | 0 |
| Gross Profit
| -38.85 | 14.751 | 8.973 | 8.746 | 20.571 | 30.78 | -5.855 | -93.44 | -69.236 | 6.681 | 0.038 | 1.125 |
| Gross Profit Ratio
| -1.152 | 0.305 | 0.177 | 0.15 | 0.244 | 0.284 | -0.06 | -1.015 | -15.147 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 16.476 | 5.516 | 5.5 | 6.983 | 24.889 | 45.143 | 36.023 | 62.061 | 24.779 | 27.704 | 23.4 | 0 |
| General & Administrative Expenses
| 4.331 | 4.615 | 7.639 | 13.128 | 12.132 | 10.901 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 4.434 | 2.657 | 0.975 | 0.793 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 8.328 | 2.657 | 8.614 | 13.921 | 12.132 | 10.901 | 30.866 | 65.507 | 47.722 | 24.395 | 11.9 | 0 |
| Other Expenses
| -4.042 | 54.648 | 53.11 | 86.461 | 148.131 | 145.629 | 126.146 | 221.11 | 101.607 | 61.587 | 37.636 | 17.628 |
| Operating Expenses
| 28.846 | 62.821 | 67.224 | 107.365 | 185.152 | 201.673 | 162.169 | 283.171 | 126.386 | 89.291 | 37.636 | 17.628 |
| Operating Income
| -67.696 | -48.07 | -58.251 | -98.619 | -164.581 | -170.894 | -179.421 | -191.101 | -121.815 | -82.609 | -37.598 | -16.503 |
| Operating Income Ratio
| -2.008 | -0.995 | -1.148 | -1.696 | -1.949 | -1.577 | -1.828 | -2.076 | -26.65 | -12.365 | -989.421 | -14.669 |
| Total Other Income Expenses Net
| 2.198 | 1.676 | -0.143 | -6.165 | 0.265 | -0.426 | -0.19 | -1.447 | 0.304 | 2.918 | -1.197 | -0.562 |
| Income Before Tax
| -65.498 | -46.394 | -58.394 | -104.784 | -164.316 | -171.319 | -179.611 | -192.548 | -121.511 | -79.691 | -38.795 | -17.065 |
| Income Before Tax Ratio
| -1.943 | -0.961 | -1.151 | -1.802 | -1.946 | -1.581 | -1.83 | -2.091 | -26.583 | -11.928 | -1,020.921 | -15.169 |
| Income Tax Expense
| 0.234 | -0.06 | 1.621 | -2.99 | 2.131 | 1.582 | 1.209 | 0.066 | 0.023 | -2.918 | 1.197 | 0.562 |
| Net Income
| -65.732 | -46.334 | -60.015 | -101.794 | -166.447 | -172.901 | -180.82 | -192.614 | -121.534 | -79.691 | -38.795 | -17.065 |
| Net Income Ratio
| -1.95 | -0.959 | -1.182 | -1.751 | -1.971 | -1.595 | -1.842 | -2.092 | -26.588 | -11.928 | -1,020.921 | -15.169 |
| EPS
| -0.69 | -0.5 | -0.67 | -1.58 | -3.72 | -4.84 | -9.12 | -10.89 | -8.55 | -6.48 | -4.13 | -1.97 |
| EPS Diluted
| -0.69 | -0.5 | -0.67 | -1.58 | -3.72 | -4.84 | -8.34 | -9.98 | -7.66 | -6.48 | -3.6 | -1.77 |
| EBITDA
| -60.628 | -39.034 | -50.979 | -84.117 | -146.814 | -161.26 | -163.434 | -188.703 | -119.528 | -79.083 | -37.021 | -16.268 |
| EBITDA Ratio
| -1.798 | -0.808 | -1.004 | -1.447 | -1.739 | -1.488 | -1.665 | -2.05 | -26.149 | -11.837 | -974.224 | -14.46 |